BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share By: Benzinga via Benzinga July 22, 2014 at 16:33 PM EDT Allergan's (NYSE: AGN) strong showing in its recent second quarter suggests an acquirer may need to offer "north of $200 a ... Read More >> Related Stocks: Macy's Valeant Pharmaceuticals International, Inc.